Biora Therapeutics, Inc. Operating Lease Cost
Biora Therapeutics, Inc. reported Operating Lease Cost of $235.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-11-14
- Biora Therapeutics, Inc. operating lease, cost for the quarter ending 2024-09-30 was $235.00K, a 24.44% decline year-over-year.
- Biora Therapeutics, Inc. operating lease, cost for the quarter ending 2024-06-30 was $235.00K, a 42.54% decline year-over-year.
- Biora Therapeutics, Inc. operating lease, cost for the quarter ending 2024-03-31 was $235.00K, a 38.80% decline year-over-year.
- Biora Therapeutics, Inc. operating lease, cost for the quarter ending 2023-12-31 was $265.00K, a 33.08% decline year-over-year.
- Biora Therapeutics, Inc. operating lease, cost for fiscal 2023 was $1.37M, a 10.58% decline from fiscal 2022.
- Biora Therapeutics, Inc. operating lease, cost for fiscal 2022 was $1.53M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $235.00K 10-Q · filed 2024-11-14 | $470.00K derived: sum of 2 quarters · filed 2024-11-14 | $706.00K 10-Q · filed 2024-11-14 | $970.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2024-06-30 | $235.00K 10-Q · filed 2024-08-12 | $470.00K 10-Q · filed 2024-08-12 | $735.00K derived: sum of 3 quarters · filed 2024-08-12 | $1.05M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2024-03-31 | $235.00K 10-Q · filed 2024-05-15 | $500.00K derived: sum of 2 quarters · filed 2024-05-15 | $811.00K derived: sum of 3 quarters · filed 2024-11-14 | $1.22M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-12-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $576.00K derived: sum of 2 quarters · filed 2024-11-14 | $985.00K derived: sum of 3 quarters · filed 2024-11-14 | $1.37M 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | $311.00K 10-Q · filed 2024-11-14 | $720.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.10M 10-Q · filed 2024-11-14 | $1.50M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $409.00K 10-Q · filed 2024-08-12 | $400.00 10-Q · filed 2023-08-14 | $793.00K 10-Q · filed 2024-08-12 | $800.00 10-Q · filed 2023-08-14 | $1.19M derived: sum of 3 quarters · filed 2024-08-12 | $1.59M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $384.00K 10-Q · filed 2024-05-15 | $400.00K 10-Q · filed 2023-05-15 | $780.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.18M derived: sum of 3 quarters · filed 2024-05-15 | $1.18M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $795.00K derived: sum of 2 quarters · filed 2024-04-01 | $795.40K derived: sum of 3 quarters · filed 2024-04-01 | $1.53M 10-K · filed 2024-04-01 | $1.50M 10-K · filed 2023-03-30 | |||
| 2022-09-30 | $399.00K 10-Q · filed 2023-11-13 | $400.00K 10-Q · filed 2022-11-14 | $399.40K derived: sum of 2 quarters · filed 2023-11-13 | $1.14M 10-Q · filed 2023-11-13 | $1.10M 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $400.00 10-Q · filed 2023-08-14 | $400.00K 10-Q · filed 2022-08-15 | $700.00 10-Q · filed 2023-08-14 | $700.00K 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-15 |